Investigating how certain genetic elements affect skin development and differentiation
Transposable elements in the keratinocyte genome and their regulation during skin development and epidermal differentiation
This study is looking at how certain genetic pieces in skin cells might affect skin development and conditions like autoimmune disorders and cancer, with the hope that the findings could help create new treatments for skin issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11026340 on NIH RePORTER |
What this research studies
This research explores the role of transposable elements (TEs) in the genome of skin cells, particularly keratinocytes, during skin development and differentiation. It aims to understand how these genetic elements are regulated and their potential involvement in skin conditions like autoimmune disorders and cancer. By examining the expression of TEs in normal skin cells and the mechanisms that control their activity, the research seeks to uncover important insights into skin health and disease. Patients may benefit from findings that could lead to new treatments for skin-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune skin conditions such as lupus erythematosus or psoriasis.
Not a fit: Patients with non-autoimmune skin conditions or those not affected by skin diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating autoimmune skin diseases and cancers.
How similar studies have performed: Other research has shown promising results in understanding the role of genetic elements in skin diseases, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Botchkarev, Vladimir a — Boston University Medical Campus
- Study coordinator: Botchkarev, Vladimir a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.